ARTL

Artelo Biosciences, Inc. - Common Stock (ARTL)

About Artelo Biosciences, Inc. - Common Stock (ARTL)

Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. Its product candidate pipeline includes ART27.13-Synthetic Cannabinoid Agonist, ART26.12-FABP5 inhibitor, and ART12.11-Synthetic CBD Cocrystal. The company was founded on May 2, 2011 and is headquartered in Solana Beach, CA.

Details

Daily high

$6.16

Daily low

$5.99

Price at open

$6.11

52 Week High

$9.30

52 Week Low

$4.92

Market cap

3.3M

Dividend yield

0.00%

Volume

6,431

Avg. volume

13,716

P/E ratio

-2.03

Artelo Biosciences, Inc. - Common Stock News